Related Experiment Videos
Cardiovascular events before and after surgery for primary hyperparathyroidism
Peter Vestergaard1, Charlotte L Mollerup, Vibe Gedsø Frøkjaer
1Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Tage Hansens Gade 2, DK-8000 Aarhus, Denmark. p-vest@post4.tele.dk
World Journal of Surgery
|March 5, 2003
Summary
Primary hyperparathyroidism increases myocardial infarction risk up to 10 years before surgery and in the first year after. Risk normalizes post-surgery, highlighting surgery
Area of Science:
- Endocrinology
- Cardiology
- Surgical Outcomes
Background:
- Primary hyperparathyroidism is linked to cardiovascular disease, including atherosclerosis and myocardial infarction (MI).
- Understanding cardiovascular event risk before and after surgery for primary hyperparathyroidism is crucial.
Purpose of the Study:
- To investigate cardiovascular events and mortality in patients undergoing surgery for primary hyperparathyroidism.
- To compare event rates and mortality between patients and matched controls.
Main Methods:
- A historical follow-up study design.
- Inclusion of 674 patients who had surgery for primary hyperparathyroidism between 1979-1997.
- Comparison with 2021 age- and gender-matched controls.
Main Results:
- Increased incidence of acute MI observed up to 10 years pre-surgery and within the first year post-surgery.
- MI risk declined to normal levels more than 1 year after surgery.
- Preoperative cardiovascular disease correlated with increased mortality risk; postoperative mortality improved over time.
Conclusions:
- Surgery for primary hyperparathyroidism is associated with a significant reduction in myocardial infarction risk post-operation.
- Early surgical intervention may be key in mitigating cardiovascular disease in primary hyperparathyroidism patients.
- While risks exist, surgical outcomes have improved, suggesting better management over time.